# Creatine-Guanidinoacetic Acid Supplementation for Sarcopenia (CREGAAS)

> **NCT04652921** · NA · COMPLETED · sponsor: **University of Novi Sad, Faculty of Sport and Physical Education** · enrollment: 30 (actual)

## Conditions studied

- Sarcopenia

## Interventions

- **DIETARY_SUPPLEMENT:** Creatine-guanidinoacetic acid
- **OTHER:** Inulin

## Key facts

- **NCT ID:** NCT04652921
- **Lead sponsor:** University of Novi Sad, Faculty of Sport and Physical Education
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-15
- **Primary completion:** 2021-12-15
- **Final completion:** 2021-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04652921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04652921, "Creatine-Guanidinoacetic Acid Supplementation for Sarcopenia (CREGAAS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04652921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*